A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects
Clinical trial NCT07529600 · COMPLETED
Trial details
- NCT number
- NCT07529600
- Sponsor
- Arnatar Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-18
- Primary completion
- 2025-12-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.